COMP <GO>
CX vs BRK-A // FREE CASH FLOW YIELD
Cemex S.A.B. de C.V. Sponsored ADR (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: CX 6
— BRK-A 7
▲ FREE CASH FLOW YIELD LEADER: CX
LAST: $10.70 (-1.20%) • MKT CAP: $16.42B
fcf-yield
2.21%
LAST: $815,600.00 (-0.23%) • MKT CAP: $1.20T
fcf-yield
2.08%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CX VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CX | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 8.30% | +1.60 | CX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 12.7x | +8.30 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 2.21% | 2.08% | +0.13 | CX | /fcf-yield <GO> |
| Operating Margin | 13.90% | 33.00% | -19.10 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 27.10% | -16.20 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 11.00% | -1.00% | +12.00 | CX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 3.02 | +0.72 | CX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | CX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.30% | -0.40 | CX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.4 | 67.2 | -5.78 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.13 | -0.14 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 16.7x | +13.80 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.42B | $1.20T | -$1.19T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CX REV | BRK-A REV | CX GROSS % | BRK-A GROSS % | CX FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $247.24B | — | 44.0% | — | $25.04B |
| FY 2024 | — | $249.71B | — | 44.0% | — | $11.62B |
| FY 2023 | — | $254.91B | — | 44.0% | — | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CX // BETA 0.99
BRK-A // BETA 1.13